Ran Chu

847 total citations
42 papers, 492 citations indexed

About

Ran Chu is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Epidemiology. According to data from OpenAlex, Ran Chu has authored 42 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Obstetrics and Gynecology, 14 papers in Reproductive Medicine and 9 papers in Epidemiology. Recurrent topics in Ran Chu's work include Endometrial and Cervical Cancer Treatments (13 papers), Ovarian cancer diagnosis and treatment (12 papers) and Cervical Cancer and HPV Research (6 papers). Ran Chu is often cited by papers focused on Endometrial and Cervical Cancer Treatments (13 papers), Ovarian cancer diagnosis and treatment (12 papers) and Cervical Cancer and HPV Research (6 papers). Ran Chu collaborates with scholars based in China, Germany and Singapore. Ran Chu's co-authors include Yunong Zhao, Jie Qiu, Siliang Wang, Guozhong Xing, Wei Zeng, Lei Qu, Xiaohui Guo, Feng Yan, Kun Song and Shu Yao and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Ran Chu

36 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Chu China 11 220 118 79 74 70 42 492
Jiaqun Li China 10 104 0.5× 28 0.2× 60 0.8× 42 0.6× 40 0.6× 20 305
Yakir Segev Israel 15 139 0.6× 34 0.3× 93 1.2× 271 3.7× 414 5.9× 79 1.1k
Jae-Bok Lee South Korea 16 149 0.7× 14 0.1× 171 2.2× 26 0.4× 12 0.2× 25 606
Xinlin Li China 9 148 0.7× 15 0.1× 51 0.6× 7 0.1× 35 0.5× 17 316
Seok-Hyun Kim South Korea 7 161 0.7× 42 0.4× 53 0.7× 3 0.0× 22 0.3× 14 378
Satoshi Kubota Japan 11 66 0.3× 12 0.1× 52 0.7× 37 0.5× 16 0.2× 36 479
Wen‐Pin Shih Taiwan 10 119 0.5× 17 0.1× 61 0.8× 27 0.4× 92 1.3× 20 426
Joon Woo Kim South Korea 14 23 0.1× 14 0.1× 127 1.6× 119 1.6× 90 1.3× 46 662
Hyun Suk Kim South Korea 10 179 0.8× 6 0.1× 169 2.1× 111 1.5× 61 0.9× 26 814
Carmen Lindsay Canada 13 45 0.2× 20 0.2× 43 0.5× 55 0.7× 2 0.0× 26 676

Countries citing papers authored by Ran Chu

Since Specialization
Citations

This map shows the geographic impact of Ran Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Chu more than expected).

Fields of papers citing papers by Ran Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Chu. The network helps show where Ran Chu may publish in the future.

Co-authorship network of co-authors of Ran Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Chu. A scholar is included among the top collaborators of Ran Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Chu. Ran Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Jun, Ran Chu, Xiaoqian Wu, et al.. (2025). Anti-biopassivated Reticular Micromotors for Bladder Cancer Therapy. Journal of the American Chemical Society. 147(21). 17936–17945. 2 indexed citations
2.
3.
Chan, Wing‐Lok, Huiqing Hou, Cheuk‐Wai Choi, et al.. (2025). Development and validation of ACTTOP: a prediction model for severe anticancer treatment toxicities in older patients with solid malignancy. Age and Ageing. 54(11). 1 indexed citations
4.
Li, Yuqing, Ping Li, Ran Chu, et al.. (2025). Association between the oxidative balance score and mortality in patients with metabolic syndrome. Scientific Reports. 15(1). 9258–9258.
5.
Li, Min, Hongyuan Zhang, Xiao Song, et al.. (2025). Risk factors for emergency cesarean delivery in patients with placenta accreta spectrum: a multicenter retrospective cohort study. Frontiers in Medicine. 12. 1539998–1539998.
6.
Liu, Yan, Wen‐Na Zhao, Ran Chu, et al.. (2024). The impact of lymphadenectomy on the survival outcomes of ovarian clear cell carcinoma: A retrospective study of the SEER database and Chinese registry. European Journal of Surgical Oncology. 50(3). 107975–107975. 1 indexed citations
7.
Zhang, Yue, Li Li, Jihong Liu, et al.. (2024). Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study. European Journal of Surgical Oncology. 50(4). 108261–108261. 2 indexed citations
9.
Liu, Qiao, et al.. (2023). Single-detector dual-modality imaging flow cytometry for label-free cell analysis with machine learning. Optics and Lasers in Engineering. 168. 107665–107665. 6 indexed citations
10.
Li, Zhuang, Ziying Wang, Zhaoyang Zhang, et al.. (2023). Prevalence of human papillomavirus DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia: a systematic review and meta-analysis. The Lancet Oncology. 24(4). 403–414. 22 indexed citations
11.
Li, Yanan, et al.. (2023). Delayed interval delivery in a quadruplet pregnancy: a case report and literature review. BMC Pregnancy and Childbirth. 23(1). 353–353. 1 indexed citations
12.
Wang, Yuanjian, Zhongshao Chen, Chang Liu, et al.. (2023). Radiomics-based fertility-sparing treatment in endometrial carcinoma: a review. Insights into Imaging. 14(1). 127–127. 3 indexed citations
13.
Qiu, Chunping, Xun Zhang, Shu Yao, et al.. (2022). HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian Cancer. International Journal of Biological Sciences. 18(3). 1188–1210. 19 indexed citations
14.
Chen, Wei, et al.. (2021). Nomogram to predict an endometrial thickness above 7.5 mm in the frozen embryo transfer cycle of women with a thin endometrium. Reproductive BioMedicine Online. 44(2). 324–332. 2 indexed citations
15.
Meng, Jinyu, Jin Peng, Jie Feng, et al.. (2021). Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer. Journal of Translational Medicine. 19(1). 415–415. 38 indexed citations
16.
Chu, Ran, et al.. (2020). Fresh versus frozen embryo transfer in women with thin endometrium: a retrospective cohort study. Annals of Translational Medicine. 8(21). 1435–1435. 12 indexed citations
17.
Xie, Lin, Ran Chu, Kai Wang, et al.. (2020). Prognostic Assessment of Cervical Cancer Patients by Clinical Staging and Surgical-Pathological Factor: A Support Vector Machine-Based Approach. Frontiers in Oncology. 10. 1353–1353. 17 indexed citations
18.
Qiu, Jie, Xiaohui Guo, Ran Chu, et al.. (2019). Rapid-Response, Low Detection Limit, and High-Sensitivity Capacitive Flexible Tactile Sensor Based on Three-Dimensional Porous Dielectric Layer for Wearable Electronic Skin. ACS Applied Materials & Interfaces. 11(43). 40716–40725. 217 indexed citations
19.
Huang, Zhen, Li Li, Shu Yao, et al.. (2018). Diagnostic accuracy of frozen section analysis of borderline ovarian tumors: a meta-analysis with emphasis on misdiagnosis factors. Journal of Cancer. 9(16). 2817–2824. 17 indexed citations
20.
Chu, Ran, et al.. (1992). A Study of Hepatitis C Virus Antibodies and Serum Alanine Amino Transferase in Blood Donors in Hong Kong Chinese. Vox Sanguinis. 62(2). 98–101. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026